$PFE Company News Acura Pharmaceuticals ends Pfizer

New Post Public Reply Private Reply Replies (0) Message Board

Apr 11, 2014 at 9:39 PM

$PFE Company News

Acura Pharmaceuticals ends Pfizer licensing pact 7:10 a.m. April 10, 2014 - MarketWatch.com
U.S. stocks fall; Nasdaq 3-day loss worst since 2011 4:48 p.m. April 7, 2014 - Victor Reklaitis
Newscast: Wall Street extends recent selloff 4:28 p.m. April 7, 2014 - MarketWatch
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Ben Eisen
Pfizer shares drop despite positive test for breast-cancer drug 1:03 p.m. April 7, 2014 - blogs.marketwatch.com
Pfizer drops 2.5% to lead Dow decliners 9:35 a.m. April 7, 2014 - William L. Watts
How sector stock funds can make your portfolio whole 7:01 a.m. April 7, 2014 - Jonathan Burton
Best, worst stocks of the $100 billion club: Morgan Stanley 2:03 p.m. March 31, 2014 - blogs.marketwatch.com
Pfizer anti-cholesterol drug meets main study goal 9:28 a.m. March 27, 2014 - MarketWatch.com
Apple looks ready to head higher 3:48 p.m. March 17, 2014 - blogs.marketwatch.com
Apple as the Comeback Kid 1:13 p.m. March 13, 2014 - Mark Hulbert
Mylan to start selling generic Celebrex in May 7:22 a.m. March 13, 2014 - MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted 3:21 p.m. March 12, 2014 - blogs.marketwatch.com
Pfizer loses ruling on Celebrex patent dispute 2:46 p.m. March 12, 2014 - Russ Britt
Trading resumes on Pfizer shares 2:37 p.m. March 12, 2014 - Russ Britt
Ruling invalidates Pfizer's Celebrex patent 2:36 p.m. March 12, 2014 - Russ Britt
Pfizer obtained reissue patent on Celebrex in 2013 2:35 p.m. March 12, 2014 - Russ Britt
Pfizer plans to appeal ruling on Celebrex judgment 2:31 p.m. March 12, 2014 - Russ Britt
Pfizer loses ruling on Celebrex patent dispute 2:30 p.m. March 12, 2014 - Russ Britt
Pfizer halted 2:15 p.m. March 12, 2014 - Steve Goldstein

Acura Pharma Ends Agreement with Pfizer - Analyst Blog 5:35 p.m. Today - Zacks.com
FDA Approves Novartis' ALK Inhibitor! Maybe...Really Soon? 3:07 p.m. Today - TheStreet.com
3 Stocks Pushing The Drugs Industry Downward 1:02 p.m. Today - TheStreet.com
Dow 30 Stock Roundup: Pfizer Drug Trial Dents, P&G Ups Dividend - Analyst Blog 11:06 a.m. Today - Zacks.com
Nektar Presents Pipeline Data - Analyst Blog 5:10 p.m. April 10, 2014 - Zacks.com
Roche's Competitive Advantage 4:22 p.m. April 10, 2014 - Seeking Alpha
A Favorable Look at Pfizer and Signet 3:54 p.m. April 10, 2014 - Barrons.com
Investors: Brace for a Turbulent Second Quarter 1:07 p.m. April 10, 2014 - FOXBusiness
French plan to allow generics alarms Big Pharma 9:32 a.m. April 10, 2014 - Seeking Alpha
Pfizer Becomes #26 Most Shorted Dow Stock, Replacing Cisco Systems 9:20 a.m. April 10, 2014 - TheStreet.com
AVERSION licensing deal terminates 8:05 a.m. April 10, 2014 - Seeking Alpha
Podcast Patent Battle Roils Big And Small Media 5:22 p.m. April 9, 2014 - Investors Business Daily
Pfizer Inc (PFE): Today's Featured Drugs Winner 5:00 p.m. April 9, 2014 - TheStreet.com
Teva to Launch Generic Lovaza - Analyst Blog 4:45 p.m. April 9, 2014 - Zacks.com
3 Stocks Reiterated As A Buy: PFE, GE, MCD 2:44 p.m. April 9, 2014 - TheStreet.com
Dow Today: Pfizer (PFE) Lower 1:00 p.m. April 9, 2014 - TheStreet.com
Top 10 Net Payout Yield Stocks For April 2014 11:19 a.m. April 9, 2014 - Seeking Alpha
Pfizer: It Never Rains, It Pours 7:24 a.m. April 9, 2014 - Seeking Alpha
Wall Street Breakfast: Must-Know News 6:31 a.m. April 9, 2014 - Seeking Alpha
Update on Merck's MK-3475 - Analyst Blog 6:35 p.m. April 8, 2014 - Zacks.com

Priority Reviews, Preliminary Earnings Releases, Clinical Trials Results, and Launch of Website - Analyst Notes on Gilead, Pfizer, Intuitive Surgical, Alkermes and Quest 10:14 a.m. Today - PR Newswire - PRF
Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts 9:00 a.m. Today - BusinessWire - BZX
Acura Pharmaceuticals Announces Return of Product Rights 6:15 a.m. April 10, 2014 - Marketwire
Thyroid Cancer Global Clinical Trials Review, H2, 2013 1:29 p.m. April 9, 2014 - PR Newswire - PRF
Enrollment in Expansion Phase of Trials, Results and Initiation of Phase 2 Studies and Stock Movements - Analyst Notes on Pfizer, Cytokinetics, Portola Pharmaceuticals, Volcano, and Array BioPharma 8:00 a.m. April 9, 2014 - PR Newswire - PRF
Diabetic Macular Edema Global Clinical Trials Review, H2, 2013 10:32 a.m. April 8, 2014 - PR Newswire - PRF
NDA Filings, FDA Approvals, Executive Appointments, Ceased Clinical Trials, and Public Offerings - Analyst Notes on Johnson & Johnson, Pfizer, Merck, GSK, and Intercept 8:00 a.m. April 7, 2014 - PR Newswire - PRF
Pfizer’s Novel CDK 4/6 Inhibitor Palbociclib plus Letrozole Significantly Prolonged Progression-Free Survival in Patients with Advanced Breast Cancer 10:30 a.m. April 6, 2014 - BusinessWire - BZX
AMCP Foundation Launches Initiative to Identify Emerging Medication Management Practices that Can Advance Patient Care and Outcomes; Project Supported by Pfizer 12:38 p.m. April 3, 2014 - PR Newswire - PRF
Exosomes Shine a Light on Alzheimer's Disease and CTE 10:16 a.m. April 3, 2014 - ACCESSWIRE
Senior Notes Conversions, FDA Drug Approvals, Acquisitions, Stock Price Updates, and Clinical Trial Studies - Analyst Notes on Gilead, Pfizer, Nordion, Intuitive Surgical, and Novartis 8:00 a.m. April 3, 2014 - PR Newswire - PRF
ViiV Healthcare announces new initiatives to improve access to dolutegravir: licence to the Medicines Patent Pool 2:30 p.m. April 1, 2014 - PR Newswire - PRF
LabCentral Announces Sponsorship by Pfizer to Support Life-Science Startup Companies in Cambridge, Massachusetts 8:30 a.m. April 1, 2014 - PR Newswire - PRF
Pfizer Statement on U.S. FDA Approval of Over-the-Counter Nexium® 24HR 6:26 p.m. March 28, 2014 - BusinessWire - BZX
Technical Summary on Active Stocks -- Research on Cisco Systems, Pfizer, Vale, and Advanced Micro Devices 11:31 a.m. March 28, 2014 - PR Newswire - PRF
Positive Opinions, Presentation Schedules of Investigational Data, Clinical Study Results, and Stock Price Movements - Analyst Notes on Johnson & Johnson, Merck, Pfizer, Amgen, and Allergan 8:00 a.m. March 28, 2014 - PR Newswire - PRF
In A Subanalysis, The Benefits Of Eliquis® (apixaban) Vs. Warfarin In Reducing The Risk Of Stroke In Patients With Nonvalvular Atrial Fibrillation Were Consistent, Regardless Of Blood Pressure Control 1 8:16 a.m. March 27, 2014 - BusinessWire - BZX
Bococizumab (RN316) Significantly Reduced LDL Cholesterol In Statin-Treated Adults With High Cholesterol In A Phase 2b Study1 8:02 a.m. March 27, 2014 - BusinessWire - BZX
Pfizer Achieves Primary Endpoint With Phase 3B Top-Line Results Of GENOTROPIN® In Very Young Children Born Small For Gestational Age 8:01 a.m. March 26, 2014 - BusinessWire - BZX
Pfizer Invites Public To View And Listen To Webcast Of May 5 Conference Call With Analysts 5:10 p.m. March 25, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASCEND® Cladding Unveils New Profiles & Texture Variety

New Options for Creative Home Exteriors Amid today's housing market rollercoaster, a sprinkle of bold innovation in building materials can make a statement—and that's precisely what Associated Materials Innovations (AMI) is banking on with their latest beef-up in the ASCEND® Composite Cladding lineup. Introduced out of Cuyahoga Falls on Sept. 8, 2026, this expansion...

Illinois' Legal Tangle: Feds Under Fire?

What a tangled web Illinois lawmakers have woven this time. They've gone and cooked up a pair of laws with a real knack for attracting attention—specifically from the folks over at the National Police Association (NPA). These aren’t your run-of-the-mill rules; they feel more like a blueprint for putting federal officers through the legal wringer and turning courtroom...

Stoke Space Raises $1B; XTEND AI Hits NYSE

A Billion-Dollar Boost for Stoke Space Ever catch wind of a company hauling in a cool billion and shrug it off? Me neither. Stoke Space Technologies just locked down $1 billion in Series E funding. This ain't some pocket change—the kind of dough you need when you're eyeing stars and plotting orbital voyages. They're gearing up for a 2027 mission with their Nova...

Life Flower Celebrates 16 Years with Dog Adoption Event

A Celebration with Heart Ah, the classic mix of business and community goodwill—that's what Life Flower Dispensary is all about this year. You know, not every business that hits the 16-year mark decides to make it about something bigger than just slashing prices or hyping themselves up. But Life Flower? They're using their anniversary to throw a shindig that's more than...

India's First Upright Proton Therapy System Unveiled

A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...

1M+ California Homes Face Extreme Wildfire Risk Revealed

Wildfire Risk in California: A Growing Alarm If there's one thing that's become a bitter truth over the years, it's that California and wildfires are inseparably linked, like mayo on a greasy diner BLT—except way worse for the gut. The latest round of data from Guidewire HazardHub is practically sounding the alarm bells louder than ever. Over a million homes in...

WaFd and EverBank $3.9B Deal Spurs Big Bank Shift

Remember the good old days when banking was just about collecting interest? Now it's all about combining forces to bolster strength, and that's just what we're seeing with WaFd, Inc. (NASDAQ: WAFD) and EverBank Financial Corp flipping the script and shaking hands on a $3.9 billion reverse merger. Strategic Vision: A New Chapter They're calling it a 'strategic...

Reliable Safety & Flow: A New Era in Infrastructure

Seismic Merger: Reliable Sprinkler and ASC Join Forces When two companies with roots stretching back to the 1800s decide to merge, it's not just a business move—it's a bold statement. Reliable Automatic Sprinkler and ASC Engineered Solutions, with over 175 years of combined innovation, have officially become Reliable Safety & Flow Corporation. This ain't just a...

Austin PostalAnnex Changes Hands After 19 Years

A Seamless Transition in Austin's PostalAnnex Legacy You know when a business digs its roots deep, becoming more than just a place but a part of the community fabric? That's what’s playing out at the PostalAnnex on W Parmer Lane, Austin. After nearly two decades, this battered yet steadfast hub of office and shipping services is swapping hands, all in the name of...

Intellectia.AI Transforming Trading with AI Upgrades

Intellectia.AI Sparks New Trading Era Intellectia.AI, from the bustling streets of New York, is cutting through the noise with a flashy update to its AI-powered trading setup. They've thrown a heap of new toys into the ring, letting folks piggyback on high-grade stock moves in the blink of an eye. Gone are the days of fumbling with cumbersome data and execution. Breaking...